BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 12:50PM EDT. Market open.
| Previous Close | 92.06 |
| Open | 92.69 |
| Bid | 91.11 x 300 |
| Ask | 91.28 x 300 |
| Day's Range | 91.01 - 93.01 |
| 52 Week Range | 76.02 - 99.56 |
| Volume | |
| Avg. Volume | 1,406,075 |
| Market Cap | 17.307B |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | 104.83 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
BioMarin (BMRN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Zacks
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Sales of AstraZeneca's (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new indications.
- Zacks
Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for BioMarin (BMRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.